High-ranking managers of biotech and pharmaceutical companies meet to engage in professional dialog at the BioPharma Cluster South Germany.

The Biotech World as Guest at the BioPharma Cluster South Germany

Uwe Bücheler was presenting the BioPharma Cluster South Germany.


Singapore, San Francisco, Shanghai, Seoul ─ and now Biberach. Some 60 high-ranking managers of biotech and pharmaceutical companies from the United States, Asia and Europe will be meeting this week to engage in professional dialog at the BioPharma Cluster South Germany. Included in the program are scheduled visits to key cluster players Teva Biotech in Ulm, Boehringer Ingelheim in Biberach and Vetter in Ravensburg. Manufacturing-related topics will also be covered, including new process technologies and innovative treatment methods involving cell and gene therapy, for example.


In his opening statement at the biotech meeting in Biberach on Tuesday, October 8, professor Uwe Bücheler mentioned that the local cluster comprising players such as Teva Biotech, Rentschler Biopharma, Boehringer Ingelheim and Vetter is nothing short of one of the world's leading biotech locations.

Board chairman of the BioPharma Cluster South Germany, he oversees the biopharma business at Boehringer Ingelheim. When it comes to the production of EU-certified active biopharmaceutical substances, the southern region of Germany is by far the country’s leading region. Outside of the United States, no other country produces more active biopharmaceutical substances than Germany. 


In Bücheler’s opinion, one of the main strengths of the cluster is that its supporting companies cater to all steps in the biopharmaceutical value-added chain ─ from discovering new substances, to preclinical development, clinical studies, all steps surrounding process development and production, through to filling, packaging and distribution.


The cluster is also well-backed in the science arena with partnering institutions Ulm University and the Biberach University of Applied Sciences. Each year, some 1,000 specialists are trained for the biotech industry in large part by the Faculty of Biotechnology at the Biberach University of Applied Sciences and other universities and regional institutions. The third pillar of the cluster comprises municipal players (cities and districts) and the Chamber of Industry and Commerce Ulm, which serves as an interface between companies, the science world and municipal partners

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.